title: Renal artery thrombosis in a pediatric case of systemic lupus erythematosus without antiphospholipid antibodies.
abstract: A 13-year-old Japanese boy with an 11-month history of systemic lupus erythematosus (SLE) without antiphospholipid antibodies (APAs) suddenly developed severe hypertension, associated with fever and generalized seizures, and mild abdominal pain. Emergency abdominal computed tomography (CT) confirmed left renal artery thrombosis, and a renal scintiscan revealed reduced blood flow to the left kidney. Promptly instituted intravenous anticoagulant therapy was not effective for controlling the infarction-reduced renal arterial blood supply. Moreover, he developed stupor due to central nervous system (CNS) lupus a week after the occurrence of the hypertensive episode. Finally, a percutaneous transluminal angioplasty successfully relieved the occlusion of the left renal artery at its origin. The CNS lupus was also successfully treated with intravenous methylprednisolone pulse therapy combined with intrathecal methotrexate and dexamethasone. Although it is well known that SLE patients with APAs have a high incidence of thrombotic complications, to date, renal artery thrombosis has rarely been reported in young patients. This APA-negative SLE patient unusually manifested renal thrombosis associated with CNS lupus.
authors: Department of Pediatrics, Hirosaki University School of Medicine, 5 Zaifu-cho, 036-5862 Hirosaki, Japan. kojituga@cc.hirosaki-u.ac.jp
authors: Koji
authors: K
authors: Tsugawa
authors: Hiroshi
authors: H
authors: Tanaka
authors: Masanobu
authors: M
authors: Kudo
authors: Tohru
authors: T
authors: Nakahata
authors: Etsuro
authors: E
authors: Ito
mesh_terms: D000293:Adolescent; D017152:Antibodies, Antiphospholipid / Q000097:blood*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D020945:Lupus Vasculitis, Central Nervous System / Q000150:complications / Q000188:drug therapy; D008297:Male; D012078:Renal Artery Obstruction / Q000150:complications* / Q000628:therapy; D013927:Thrombosis / Q000150:complications* / Q000628:therapy
chemical_list: D017152:Antibodies, Antiphospholipid